A00468 Summary:

COSPNSRMagee, Brindisi, Gunther, Russell, McDonald
MLTSPNSRLupardo, Stec
Add S391-oo, Gen Bus L
Regulates the sale of methamphetamine precursor drugs.
Go to top    

A00468 Actions:

01/07/2015referred to consumer affairs and protection
01/06/2016referred to consumer affairs and protection
Go to top

A00468 Memo:

submitted in accordance with Assembly Rule III, Sec 1(f)
SPONSOR: Cymbrowitz (MS)
  TITLE OF BILL: An act to amend the general business law, in relation to the sale of over-the-counter methamphetamine precursor drugs   PURPOSE OR GENERAL IDEA OF BILL: To implement an electronic tracking system on the sale of products containing pseudoephedrine, or ephedrine. This system will communicate in real time, across state lines and produce a stop sale notification to the seller of the product.   SUMMARY OF SPECIFIC PROVISIONS: Creates a new section in the general business law, Section 391-oo, including but not limited to, the following provisions: -limits the over the counter sale to packages containing not more than 3.6 grams of one or more methamphetamine precursor drugs, not to exceed 9 grams within a 30 day period; -requires presentation of valid, government issued, photo identifica- tion; -requires the buyer to sign a written or electronic logbook to be retained by the seller, which the seller shall maintain for at least three years and be open to inspection by law enforcement; -requires a retailer, before completing a sale, to electronically submit the required information to the real-time, stop-sale system administered by the division of state police; -retailers are only required to participate as long as the system is provided free of charge; -imposes civil penalties on those who sell methamphetamine precursor drugs in violation of this law; -provides immunity for retailers that violate this section without negligence, wantonness, recklessness, or deliberate misconduct; -the real-time, stop-sale system is capable of generating a stop sale alert, which is a notification that completion of the sale would result in the retailer or purchaser violating the quantity limits set forth in this section. The retailer shall not complete the sale if the system generates a stop sale alert, unless threatened by imminent bodily harm.   JUSTIFICATION: In 2005, the federal government enacted the Combat Methamphetamine Epidemic Act of 2005 (CMEA), which regulates retail over-the-counter sales of ephedrine, pseudoephedrine, and phenylpropanolamine products because of their use in the manufacture of illegal drugs, specifically methamphetamine. They are also common ingredients used to make cough, cold, and allergy products. Retail provisions of the CMEA include daily sales limits and 30-day purchase limits. Placement of product out of direct customer access, sales logbooks, customer ID verification, employee training, and self-certification of regulated sellers. Such legislation is necessary because it is common for persons manufacturing methamphetamine to recruit other people to purchase these precursors. While the CMEA has been helpful to law enforcement when investigating persons suspected of manufacturing methamphetamine, because no such provisions exist in state law, local law enforcement and district attor- ney's offices cannot pursue violations of purchase limits. States have led the effort to address the rapid growth of clandestine methamphetamine labs and methamphetamine abuse, by passing laws similar to the CMEA regulating the sale of drugs containing methamphetamine precursors. In fact, nearly all states have passed laws regulating the sale of precursors to methamphetamine. New York's laws regarding meth- amphetamine are found in the penal code, but such provisions are limited to possession of precursors and manufacturing materials and actual meth- amphetamine production. As almost every other state has done, this bill codifies many of the same standards found in the CMEA, in an effort to thwart the "spider-web" process that occurs when methamphetamine manufacturers send multiple people out to purchase precursors on their behalf. Furthermore, participation in an electronic tracking system has already been implemented by 26 states. The U.S. Department of Justice claims that states that have enacted similar or more restrictive retail regulations have seen a dramatic drop in small clandestine labs.   PRIOR LEGISLATIVE HISTORY: 2012 A.8384C referred to consumer affairs and protection 2012 S.6866-B 2014 A.1359-C referred to consumer affairs and protection S.4652-B   FISCAL IMPLICATIONS: None. The real-time, stop-sale system shall be free of charge to the retailer. This system is fully funded by the Consumer Healthcare Products Associ- ation (CEPA), which is a member-based organization of manufacturers and distributors of non-prescription, over-the-counter medicines and supple- ments.   EFFECTIVE: This act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amendment, and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date is authorized to be made on or before such date.
Go to top